Eskatrol

From Wikipedia, the free encyclopedia

Eskatrol was the brand name of a combination prescription drug manufactured by Smith, Kline & French Laboratories and marketed in the United States as an appetite suppressant and weight loss agent ("diet pill").. The product's active ingredients comprised the central nervous system (CNS) stimulant, dextroamphetamine sulfate and the typical antipsychotic, prochlorperazine[1]the former of which was also manufactured by Smith, Kline, & French and marketed on its own as Dexedrine.[2] Eskatrol was among the 200 most commonly-prescribed medications in the U.S. in the early 1980s, when in 1981, the U.S. Food and Drug Administration (FDA) mandated the product cease production and be withdrawn from the market,[3][2] on the assertion that SF&K had to failed to prove the medication's therapeutic efficacy (Emax).

Withdrawal of Combination Anorectics from the US market

See also

References

Related Articles

Wikiwand AI